Whats new

Whats new.

goetzpartners securities -Data highlights efti efficacy and potential central role in cancer therapy - Reiterate OUTPERFORM and TP of AUD 1.350

November 17th 2021

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

Go back